Clinical Trials on Ocular Hypertension in United Kingdom

Total 5476 results

Allergan

Completed

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Innovative Medical

Completed

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

Glaucoma

United States
Santen Inc.

Completed

Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6

Primary Open-angle Glaucoma and Ocular Hypertension

United States
Aerie Pharmaceuticals

Completed

Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma or Ocular Hypertension

United States
Cornerstone Health Care, PA
Allergan

Completed

Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)

Ocular Hypertension | Glaucoma

United States
Alcon Research

Completed

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Aerie Pharmaceuticals

Completed

Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Alcon Research

Completed

Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Completed

A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Ocular Hypertension | Glaucoma

United States
Chakshu Research, Inc.

Completed

An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

Ocular Hypertension

United States
Allergan

Completed

Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®

Ocular Hypertension | Glaucoma

United States
Mayo Clinic

Terminated

Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear

Ocular Hypertension

United States
University of Houston

Completed

The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width

Ocular Hypertension

United States
Intuor Technologies, Inc.

Completed

Clinical Evaluation of CATS Tonometer Prism

Ocular Hypertension

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.

Glaucoma

United States, Spain, Serbia, Ukraine, Belgium, Italy, Portugal, France, Slovenia, Germany, Poland, Czechia, Philippines, Colombia, India, Romania, Russian Federation, Slovakia, South Africa, United Kingdom
Bausch & Lomb Incorporated

Completed

Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT (JUPITER)

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Sensimed AG
Yale University

Terminated

IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients

Ocular Hypertension

United States
United States Naval Medical Center, San Diego

Completed

Intraocular Pressure During Robotic Assisted Laparoscopic Procedures Utilizing Steep Trendelenburg Positioning

Ocular Hypertension

United States
University of Nebraska

Completed

Circadian Rhythms of Aqueous Humor Dynamics When Using Brimonidine in Humans With Ocular Hypertension

Glaucoma Suspects

United States
Innovative Medical

Completed

A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension

Glaucoma

United States
Santen Inc.

Completed

DE-117 Spectrum 5 Study

Primary Open-angle Glaucoma and Ocular Hypertension

United States
Philadelphia Eye Associates
Pfizer

Completed

Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops

Ocular Hypertension | Glaucoma

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

United Kingdom, France, Australia, Thailand, Portugal, Pakistan, Czechia, Greece
Allergan

Completed

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension

Germany, Canada, United States, Austria
Allergan

Completed

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects

Ocular Hypertension | Glaucoma

Canada, United States
Oregon Health and Science University
National Eye Institute (NEI)

Recruiting

Functional and Structural Imaging for Glaucoma (FSOCT)

Glaucoma

United States
University of Nebraska

Terminated

Comparison of Latanoprost Vs. Timolol

Glaucoma

United States
Benjamin Frankfort, MD, PhD

Terminated

Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma (HOCD)

Glaucoma

United States
University of Alabama at Birmingham

Completed

Glaucoma Management Optimism for African Americans Living With Glaucoma (GOAL)

Glaucoma

United States
Noveome Biotherapeutics, formerly Stemnion

Completed

Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects

Ocular Hypertension

United States
Wills Eye
Allergan; The American Society of Cataract and Refractive Surgery Foundation

Enrolling by invitation

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

Ocular Hypertension | Glaucoma

United States
NYU Langone Health

Completed

NIDEK Gonioscope GS-1 for Glaucoma

Glaucoma

United States
Boston Medical Center

Completed

Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center

Glaucoma

United States
Doheny Image Reading Center

Completed

Testing Latest Version of NidekRS3000Adv

Glaucoma

United States
Wills Eye
Genentech, Inc.; Novartis Pharmaceuticals

Completed

Lucentis Versus Mitomycin C During Glaucoma Surgery

Glaucoma

United States
The University of Texas Health Science Center,...
Robert Cizik Eye Clinic

Terminated

Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period

Glaucoma

United States
Massachusetts Eye and Ear Infirmary

Completed

Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma

Glaucoma

United States
University of Colorado, Denver
Genentech, Inc.

Completed

Use of Ranibizumab With Mitomycin C During Trabeculectomy (OCTOPUS)

Glaucoma

United States
University of Miami
National Eye Institute (NEI); Research to Prevent Blindness

Completed

Ahmed Versus Baerveldt Comparison Study (ABC)

Glaucoma

United States
University of Wisconsin, Madison

Completed

Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects (OMT4OHT)

Ocular Hypertension | Glaucoma

United States
University of Kentucky

Terminated

Effects of Selective Laser Trabeculoplasty (SLT)

Glaucoma

United States
University of Colorado, Denver

Completed

Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients

Glaucoma

United States
Johns Hopkins University

Completed

Eyelid Closure in Glaucoma Therapy

Glaucoma

United States

3

Subscribe